Accendra Health, Inc. (ACH) Fair Value 2026

ACH · Medical Distribution ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.4 /10

32 fundamental signals · 9 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-07-15, Accendra Health, Inc. (ACH) trades at $3.61, approximately 765% above CirclFi’s Bayesian DCF fair value of $0.42. QOC: 5.4/10. Value Trap Risk: 53/100 (WARN). 9/13 models active.

Key Facts

Ticker
ACH
Price
$3.61
Quality Score
5.4/10
Value Trap Risk
53/100
Models Active
9/13
Last Updated
Strength: First Chicago suggests +243.8% upside with 54% confidence
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

Is Accendra Health, Inc. (ACH) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, Accendra Health, Inc. (ACH) appears undervalued as of : the median of 9 independent fair value estimates is $9.80, 171.6% above the current price of $3.61. Estimates range from $0.42 to $18.41. ACH scores 5.4/10 on fundamental quality and 53/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Accendra Health, Inc. Stock in 2026? →

Valuation Matrix

9 Intrinsic Value Models vs. Current Price ($3.61)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
 $0.42 -88.4%
CUCE Ensemble
Low Conviction
 $9.80 +171.6%
First Chicago
High Conviction
 $12.41 +243.8%
EROIC Spread
High Conviction
 $4.76 +31.9%

Unlock the Full Matrix

Access 5 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is Accendra Health, Inc. (ACH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Accendra Health, Inc.. Trading at $3.61 against an estimated intrinsic value of $9.39, 7 of 9 active models flag meaningful upside of +160.1% on average. The most optimistic model, Regime Cross, places fair value at $18.41 (+409.9%), while Bayesian DCF — the most conservative — estimates $0.42 (-88.4%). This +498.3% gap reflects genuine analytical uncertainty about Accendra Health, Inc.'s intrinsic worth.

What Do the Models Say About ACH?

9 of 13 models are currently active for ACH. Of these, 7 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates ACH's intrinsic value at $0.42, implying -88.4% downside from the current price. See which stocks rank higher →

How Does ACH Rank in Medical Distribution?

Among 2 Medical Distribution stocks, ACH ranks #1 by Quality of Company score. CirclFi's QOC score of 5.4/10 evaluates 32 fundamental signals. A score of 5.4 reflects mixed fundamentals.

Accendra Health, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ACH a Value Trap?

CirclFi's Value Trap algorithm assigns ACH a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for Accendra Health, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Accendra Health, Inc. scores 5.4 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +498.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ACH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ACH's 9 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Accendra Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Distribution Stocks Should You Also Analyze?

1 related Medical Distribution stocks with 13-model coverage

AHGAkso Health GroupQOC 1.9

Read investment analysis: AHG

Frequently Asked Questions About Accendra Health, Inc.

What is Accendra Health, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Accendra Health, Inc. (ACH) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.42. The Quality of Company score is 5.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ACH overvalued or undervalued right now?

At $3.61, 7 of 9 active models suggest ACH may be undervalued, while 2 indicate potential overvaluation. The median of all 9 fair value estimates is $9.80, 171.6% above the current price of $3.61 — a consensus view that ACH is undervalued. The assessment depends on which methodology best fits Accendra Health, Inc.'s business model in Medical Distribution.

What does a Quality of Company score of 5.4 mean for ACH?

Accendra Health, Inc.'s QOC of 5.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ACH?

CirclFi analyzes ACH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Is ACH a value trap in 2026?

Accendra Health, Inc.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 9-model valuation engine, Accendra Health, Inc. (ACH) has a median fair value of $9.80 — 171.6% above the current price of $3.61 — as of 2026-07-15.” Source: circlfi.com/stock/ACH/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on ACH.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access